- Home
- LPG vs OGN Comparison
LPG vs OGN Comparison
Compare LPG & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | OGN |
|---|---|---|
| Founded | 2013 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LPG | OGN |
|---|---|---|
| Price | $38.91 | $13.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $39.33 | $11.40 |
| AVG Volume (30 Days) | 388.5K | ★ 14.9M |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.26% | 0.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.64 | 0.72 |
| Revenue | $353,341,476.00 | ★ $6,216,000,000.00 |
| Revenue This Year | $35.73 | $0.45 |
| Revenue Next Year | N/A | $1.67 |
| P/E Ratio | ★ $14.64 | $18.42 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.60 | $5.69 |
| 52 Week High | $39.45 | $13.39 |
Technical Indicators
Market Signals| Indicator | LPG | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 67.31 | 78.82 |
| Support Level | $29.47 | $6.31 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.32 | 0.53 |
| MACD | 0.25 | 0.46 |
| Stochastic Oscillator | 89.52 | 98.00 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About OGN Organon & Co.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.